We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





World's First 5-Minute Real-Time PCR Instrument Debuts at ADLM 2024

By LabMedica International staff writers
Posted on 30 Jul 2024
Print article
Image: The XDive 5-minute real-time PCR instrument is on display at ADLM 2024 (Photo courtesy of OnsiteGene Inc.)
Image: The XDive 5-minute real-time PCR instrument is on display at ADLM 2024 (Photo courtesy of OnsiteGene Inc.)

OnsiteGene Inc. (San Diego, CA, USA) is introducing the new XDive, the world's first 5-minute real-time PCR instrument, at the Association for Diagnostics & Laboratory Medicine (ADLM) 2024 conference. This groundbreaking innovation completes 40 thermal cycles and real-time fluorescent imaging in just five minutes while maintaining sensitivity comparable to leading brands on the market.

OnsiteGene's XDive 5-minute PCR is an ultra-fast real-time PCR analysis platform that integrates high-speed thermal cycling, ultra-fast PCR reaction reagents, and real-time fluorescence data acquisition workflows. XDive can perform up to 16 ultra-fast reactions per experiment, providing moderate sample throughput and maximum working flexibility. It uses proprietary heating blocks, sensors, and algorithms to achieve ultra-fast ramp rates and superior temperature control accuracy. Its optical system consists of four fluorescence channels, which can be detected by multiplex real-time PCR analysis in minutes. XDive's unique TaqMan chemistry has been optimized for ultra-fast operating conditions. XDive reaction tubes accommodate reaction volumes on conventional PCR instruments, resulting in highly accurate and reproducible results for very ultra-fast fluorescence PCR analysis. The software structure of the system is simple and reasonable, and it is easy to operate.

OnsiteGene's original XDive 5-minute ultra-fast real-time PCR instrument can be easily integrated into new systems as an OEM module, significantly increasing productivity and flexibility, as well as reducing application costs. With OnsiteGene’s 5 minutes superfast magnetic bead nucleic acid extraction instrument (Xtractor) and reagent, users can also develop new ultra-fast real-time PCR applications on the XDive system with 16 sample throughput in as fast as 10 minutes from sample to answer for point-of-care molecular testing and other applications. The instrument has received FDA Emergency Use Authorization (EUA) for COVID-19 and Monkeypox testing using swab or saliva samples.

XDive's editable panel technology simplifies the regulatory process for developing test kits and syndromic panels, significantly reducing time, cost, and risk. The superfast master mix used in the XDive instrument is in a dried form, allowing for easy shipping and storage at room temperature with a shelf life of 6 months. OnsiteGene has also developed the XPrep module, designed to extract RNA/DNA and seamlessly load XDive cartridges. With the XPrep module, XDive instruments provide a comprehensive and flexible sample-to-answer platform with up to 96-sample throughput, up to 256 multiplexing targets, and a 30-minute turnaround time.

Related Links:
OnsiteGene Inc.

New
Gold Member
Veterinary Hematology Analyzer
Exigo H400
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
New
Lyme Disease Test
Lyme IgG/IgM Rapid Test Cassette
New
Troponin I Test
Quidel Triage Troponin I Test

Print article

Channels

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Pathology

view channel
Image: Microscopic images showing healthy villi on the left and diseased villi on the right (Photo courtesy of Florian Jaeckle/University of Cambridge)

Powerful AI Tool Diagnoses Coeliac Disease from Biopsy Images with Over 97% Accuracy

Coeliac disease is an autoimmune disorder triggered by the consumption of gluten, causing symptoms such as stomach cramps, diarrhea, skin rashes, weight loss, fatigue, and anemia. Due to the wide variation... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.